Affinity Asset Advisors »

Eupraxia Pharmaceuticals shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Eupraxia Pharmaceuticals (EPRX) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Eupraxia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eupraxia Pharmaceuticals held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eupraxia Pharmaceuticals by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.8M 300k 5.90

More positions owned by Affinity Asset Advisors

Insmed Com Par $.01 (INSM)
Verona Pharma Sponsored Ads (VRNA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Xenon Pharmaceuticals (XENE)
Madrigal Pharmaceuticals (MDGL)
Apogee Therapeutics (APGE)
Arcellx Common Stock (ACLX)
Alkermes SHS (ALKS)
Nuvalent Inc-a (NUVL)
Abivax Sa Sponsored Ads (ABVX)
Mineralys Therapeutics (MLYS)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Merus N V (MRUS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Lexeo Therapeutics (LXEO)

View all positions for Affinity Asset Advisors

Top funds holding Eupraxia Pharmaceuticals

Beutel, Goodman & Company
Balyasny Asset Management
Vivo Capital
Scotia Capital
Dr. Jeffrey R. Jay, M.D.
Ally Bridge Group
Logos Global Management
Royal Bank of Canada
Velan Capital Investment Management
Affinity Asset Advisors
Alyeska Investment Group
UBS Group
Ingalls & Snyder
Goldman Sachs Group
Bank Of Montreal

View all funds holding Eupraxia Pharmaceuticals